Harvard Bioscience Inc
HBIO
Revenue
23.10M
▼-1.42M▼-5.77%
3 Months ChangeAssets
128.91M
▼-4.25M▼-3.19%
3 Months ChangeLiabilities
61.67M
▼-2.68M▼-4.17%
3 Months ChangeFree Cash Flow
758.00k
▼-830.00k▼-52.27%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-08
Form 10-Q
ID: 0001171843-24-004564
2024-08-08
Form 8-K
ID: 0001171843-24-004562
2024-05-14
Form 8-K
ID: 0001171843-24-002878
2024-05-07
Form 10-Q
ID: 0001171843-24-002618
2024-05-07
Form 8-K
ID: 0001171843-24-002591
2024-04-03
Form 8-K
ID: 0001171843-24-001791
2024-03-26
Form 8-K
ID: 0001171843-24-001609
2024-03-07
Form 8-K
ID: 0001171843-24-001222
2024-01-05
Form 8-K
ID: 0001171843-24-000099
2023-11-07
Form 10-Q
ID: 0001171843-23-006831